Skip to main content
. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021

TABLE 4.

Comparison of antifibrotic agents

Pirfenidone Nintedanib
Number of tablets [85 ] 3–12# 2
Side effects [8688] Nausea, anorexia, weight loss, photosensitivity, rash, elevated liver enzymes Diarrhoea, weight loss, elevated liver enzymes
Outdoor occupation/hobby [86] +
Anticoagulation therapy [89] +
Ischaemic heart disease [87, 89] +
Cost [90]
Newly planned/major surgery [91] +
Impact on quality of life [85] + +
Prevention of acute exacerbation and/or respiratory-related hospitalisations [9294] + +

A “+” possibly denotes the preferred drug of choice. #: pill burden will vary, depending on the strengths available in different countries; : it is important to understand that the cost of these drugs varies across countries, insurance providers and healthcare providers (public versus private).